News

In The News ADVI Health Welcomes David Liu as a Healthcare Data Analyst
In The News AVBCC 2022 Key Takeaways: The impact of the IRA is beyond impacts to pricing
In The News Seasoned Healthcare Marketing Executive Joins ADVI As Head of Marketing
In The News ADVI Health Welcomes Policy & Reimbursement Expert Brenna Raines
In The News ADVI’s Lindsay Bealor Greenleaf told BioWorld that whether the launch interchangeable insulin biosimilars will result in lower costs for patients will be decided by PBMs.
In The News ADVI’s Lindsay Bealor Greenleaf spoke to BioWorld about the latest congressional scrutiny around prescription drug list price increases and the overlooked role played by pharmacy benefit managers.
In The News ADVI’s Lindsay Bealor Greenleaf spoke to AISHealth about CMS’ recent proposal to rein in pharmacy price concessions imposed by pharmacy benefit managers
In The News ADVI’s Lindsay Bealor Greenleaf spoke to AIS Health about a new report on PBMs & their ability to manufacture profits at the expense of patients.
In The News The House passed the Build Back Better reconciliation bill on Friday, which includes authorization for the government to negotiate lower drug prices. ADVI Health’s Lindsay Bealor Greenleaf shared insights on the measure with Pharmacy Times